FDA paves way for Pfizer COVID-19 vaccinations in young kids
By MATTHEW PERRONE and LAURAN NEERGAARD Associated Press WASHINGTON (AP) — The Food and Drug Administration has paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The agency authorized the kid-size doses on Friday. But there’s one more regulatory hurdle. Next week, advisers to the Centers for Disease Control and
Continue Reading